Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

19

Number of overlapping holdings

47.5%

% of HRTS's 41 holdings also in XLV

31.7%

% of XLV's 60 holdings also in HRTS

Overlap by Weight
Sector Drift (HRTS minus XLV)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in HRTS
Weight
in XLV
Overlap
ELI LILLY & CO 10.9% 13.4% 10.9%
UNITEDHEALTH GROUP INC 5.6% 8.5% 5.6%
ABBOTT LABORATORIES 4.0% 4.6% 4.0%
BOSTON SCIENTIFIC CORP 3.1% 2.8% 2.8%
THERMO FISHER SCIENTIFIC INC 2.8% 3.3% 2.8%

Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to XLV
BRIDGEBIO PHARMA, INC. 4.3%
ASTRAZENECA PLC 4.0%
NOVO NORDISK A/S-B 3.9%
ROCHE HOLDINGS LTD-SPONS ADR 3.9%
NOVARTIS AG 3.1%
CRINETICS PHARMACEUTICALS INC 2.8%
CHUGAI PHARMACEUTICAL CO LTD 2.3%
CYTOKINETICS INC 2.3%
ALNYLAM PHARMACEUTICALS INC 1.9%
ASCENDIS PHARMA A/S 1.8%
HRTS Underweight Relative to XLV
JOHNSON & JOHNSON -7.7%
ABBVIE INC -4.1%
INTUITIVE SURGICAL INC -3.5%
UNITEDHEALTH GROUP INC -2.9%
PFIZER INC -2.5%
ELI LILLY & CO -2.5%
STRYKER CORP -2.4%
ELEVANCE HEALTH INC -2.0%
CIGNA CORPORATION -1.8%
CVS CAREMARK CORP -1.7%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY